Recursion Pharmaceuticals Announces Formation of Its Scientific and Technical...
Recursion Pharmaceuticals is a start-up biotech firm in Salt Lake City with a goal of discovering new therapeutics for the treatment of rare genetic diseases. Recursion announced the formation of its...
View ArticleRecursion Pharmaceuticals Announces Dr. H. Perry Fell as the First Member of...
Recursion Pharmaceuticals, a biotech start-up in Salt Lake City today announced the formation of its Business Advisory Panel. The first appointment to the Advisory Panel is H. Perry Fell, MBA, Ph.D....
View ArticleRecursion Pharmaceuticals Announces Funding for Rett Syndrome Research
Recursion Pharmaceuticals has received support for focused work to identify a treatment for Rett Syndrome by the Rett Syndrome Research Trust. Recursion will apply its innovative drug discovery...
View ArticleRecursion Pharmaceuticals Announces Funding Support for Ataxia-Telangiectasia
Recursion today announced a grant from the AT-Children's Project to advance it's innovative drug discovery work towards identifying novel treatments for ataxia-telangiectasia, a brutal childhood...
View ArticleH. Perry Fell, Experienced BioTech Executive, Joins Board of Recursion...
H. Perry Fell, past CEO of Seattle Genetics and NanoString, joins the Board of Recursion Pharmaceuticals. Recursion is an emerging biotech company seeking to combine the best elements of computation...
View ArticleRecursion Pharma Receives Orphan Drug Designation for Hereditary Stroke Disorder
Recursion Pharmaceuticals, a drug discovery start-up company, announced receipt of an Orphan Drug Designation from the FDA for the use of Tempol for the treatment of Cerebral Cavernous Malformation, a...
View ArticleRecursion Pharmaceuticals Receives $2.6 Million in Follow-on Seed Funding
Funding will be used to accelerate and scale the company’s proprietary drug discovery platform. [PR.com]
View ArticleRecursion Pharmaceuticals Supports White House Precision Medicine Initiative
Recursion Pharmaceuticals today announced that it is part of a group of nationally recognized private and public institutions making commitments as part of President Obama's Precision Medicine...
View Article
